KLP Kapitalforvaltning AS purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 40,800 shares of the medical instruments supplier’s stock, valued at approximately $780,000.
A number of other large investors have also made changes to their positions in the company. Riverview Trust Co acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB grew its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Quarry LP raised its holdings in DENTSPLY SIRONA by 455.0% during the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after buying an additional 2,489 shares during the period. Finally, Signaturefd LLC lifted its stake in DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 3,706 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on XRAY. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research cut their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Finally, UBS Group decreased their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $23.33.
DENTSPLY SIRONA Trading Up 0.1 %
DENTSPLY SIRONA stock opened at $14.94 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a 50-day simple moving average of $17.55 and a 200 day simple moving average of $20.05. The stock has a market capitalization of $2.97 billion, a P/E ratio of -7.22, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52 week low of $14.61 and a 52 week high of $33.22.
DENTSPLY SIRONA Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.28%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.
Insider Buying and Selling at DENTSPLY SIRONA
In related news, Director Gregory T. Lucier acquired 15,142 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.52% of the company’s stock.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
- Five stocks we like better than DENTSPLY SIRONA
- How to Invest in Small Cap StocksĀ
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Canadian Penny Stocks: Can They Make You Rich?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.